COMPOSITIONS COMPRISING 5-(3-ETHYL-1,2,4-OXADIAZOL-5-YL)-1,4,5,6-TETRAHYDROPYRIMIDINE, AND METHODS OF ADMINISTERING SAME

摘要

The present disclosure is directed to cognition-enhancing pharmaceutical compositions and dosage forms comprising an amount of 5-(3-ethyl-1,2,4-oxadiazol-5- yl)-1,4,5,6-tetrahydropyrimidine, or pharmaceutically acceptable form thereof, that cause at most only moderate cholinergic side effects in an animal receiving the composition.